查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1836331

2032 年生物骇客补充剂和设备市场预测：按产品类型、技术、应用、最终用户和地区进行的全球分析

Biohacking Supplements & Devices Market Forecasts to 2032 - Global Analysis By Product Type (Nootropics, Adaptogens, Metabolic Boosters, Sleep Aids and Implants), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球生物骇客补充剂和设备市场预计在 2025 年达到 294 亿美元，到 2032 年将达到 991 亿美元，预测期内的复合年增长率为 18.9%。

生物骇客补充剂和设备旨在透过科学支持的干预措施来优化人类的表现、寿命和福祉。这些措施包括精神活性药物、适应原、穿戴式装置、神经刺激装置和代谢追踪器。使用者的目标是增强认知功能、睡眠、精力和细胞健康。生物骇客深受健康爱好者和科技爱好者的欢迎，它融合了生物学、营养学和技术，突破了个人健康的界限，通常带有 DIY 的理念，并专注于可衡量的、数据驱动的结果。

据美国营养协会 (ANA) 称，生物骇客技术和补充剂正在透过精准营养、精神药物和穿戴式生物感测器推动自我优化，以增强认知和代谢性能。

穿戴式健康追踪器的普及率不断提高

穿戴式装置市场的成长驱动力在于其使用率的不断成长。这些设备可以监测生命征象、睡眠模式和体力活动，使个人能够即时追踪生物骇客攻击的进展。在感测器技术进步的推动下，这些工具可以无缝融入日常生活。消费者越来越多地利用穿戴式装置来支持个人化健康、预防性医疗保健和长寿实践。智慧型手錶、健身手环和植入式追踪器的普及正在推动穿戴式装置的普及。对数位监控的日益依赖，使得生物骇客解决方案更容易取得，也更具可扩展性。

先进生物黑客设备的高成本

由于先进的生物黑客技术成本高昂，市场面临挑战。植入式晶片、连续血糖监测仪和神经刺激工具等设备价格昂贵，限制了大众消费者的普及。高额的研发投入和製造复杂性进一步提高了价格结构。此外，许多保险公司将增强型医疗设备排除在保险范围之外，将其归类为非必需品而非必需品。这些成本障碍主要限制了富裕人口和早期采用者的采用。因此，负担能力仍然是一个重要的限制因素，阻碍了更广泛的市场渗透。

与人工智慧主导的个人化健康相结合

将人工智慧与生物骇客解决方案结合，打造个人化健康路径，蕴藏着巨大的机会。人工智慧主导的分析技术可以解读来自穿戴式装置、诊断工具和补充剂的大量资料集，为使用者提供切实可行的洞察。在数位健康技术的推动下，对代谢、认知和荷尔蒙指标的预测性监测已成为可能。个人化推荐可以优化补充剂、饮食和运动方案。此外，人工智慧平台透过自适应回馈迴路增强用户参与度。生物骇客与人工智慧创新的融合有望透过可扩展的数据主导解决方案再形成市场。

关于人类增强的伦理问题

围绕人类增强和增强实践日益激烈的伦理争论，使生物骇客市场面临重大威胁。公众的质疑通常集中在使用先进生物骇客工具的安全性、隐私性和公平性。批评者认为，神经增强和基因改造会改变人类的自然行为，引发道德上的关切。监管机构正日益严格地审查这些技术的长期影响和潜在的滥用风险。这些伦理挑战可能导致更严格的政策出台，并损害消费者的信任。因此，解决社会关切对于永续的市场成长仍然至关重要。

COVID-19的影响：

疫情再形成了消费者对生物骇客和预防性健康的观点。人们对免疫力、压力管理和整体復原力的认识不断提高，加速了人们对补充剂和数位监控设备的兴趣。同时，全球供应链中断和设备成本上升导致产品供应暂时中断。远端保健的普及以及精神活性药物、穿戴式装置和健康工具线上销售的成长抵消了线下销售的下滑。疫情过后，消费者维持了良好的健康习惯，维持了生物骇客创新的动能。整体而言，新冠疫情起到了催化剂的作用，加深了全球整体自我优化实践的参与。

预计精神药物市场将成为预测期内最大的市场

由于消费者对认知增强和精神表现的兴趣日益浓厚，预计精神药物领域将在预测期内占据最大的市场份额。针对注意力、记忆力和减压的补充剂在学生、专业人士和老年人群体中越来越受欢迎。工作生活压力的增加导致对天然和合成精神药物的需求激增。线上销售和订阅模式增加了这些药物的供应。此外，围绕大脑健康的强劲行销也促进了其应用。这一领域仍然是生物骇客应用的核心。

预计基于人工智慧的监控领域在预测期内将以最高的复合年增长率成长

受即时数据分析和穿戴式装置整合技术进步的推动，基于人工智慧的监测领域预计将在预测期内实现最高成长率。这些平台提供新陈代谢、睡眠和压力管理的预测性洞察，以优化个人健康策略。在智慧型装置的快速普及推动下，消费者对人工智慧驱动的个人化服务的需求日益增长。云端基础的平台进一步增强了扩充性和可访问性。医疗保健提供者和生物骇客都在整合人工智慧来完善建议。人工智慧与生物骇客的融合使监测技术成为高成长前沿。

比最大的地区

在预测期内，由于健康意识的增强、可支配收入的增加以及智慧健康设备的快速普及，亚太地区预计将占据最大的市场份额。中国、日本、韩国和印度等国家对精神药物和穿戴式科技的需求强劲，推动着该地区的成长。传统保健方法与现代生物黑客补充剂的结合，进一步增强了该地区的生物黑客补充剂的普及。数位医疗基础设施投资的不断增加也提高了生物骇客补充剂的可近性。综合来看，这些因素使亚太地区在全球生物骇客补充剂的销售中占据主导地位。

复合年增长率最高的地区：

在预测期内，北美预计将呈现最高的复合年增长率，这得益于其强劲的技术创新和生物骇客解决方案的早期应用。美国和加拿大消费者对精神药物、基因检测套组和穿戴式健康追踪器的接受度很高。大型生物技术公司和健康新兴企业的出现正在加速产品开发。此外，该地区强大的数位生态系统支援采用人工智慧主导的监测技术。人们对个人化健康和预防性医疗保健日益增长的兴趣进一步推动了这一发展势头。这些动态使北美成为成长最快的市场区域。

免费客製化服务

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球生物黑客补充剂和设备市场（按产品类型）

  • 益智药
  • 适应原
  • 代谢加速器
  • 助眠剂
  • 植入

6. 全球生物骇客补充剂和设备市场（按技术）

  • 基于人工智慧的监控
  • 物联网设备
  • 数据分析

第七章全球生物骇客补充剂和设备市场（按应用）

  • 提升认知能力
  • 体能
  • 长寿
  • 减轻压力
  • 优化睡眠

第八章全球生物骇客补充剂和设备市场（按最终用户）

  • 运动员
  • 在职专业人士
  • 生物骇客
  • 健康爱好者
  • 高龄化社会

9. 全球生物骇客补充剂和设备市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Apple
  • Fitbit
  • Health Via Modern Nutrition（HVMN）
  • WHOOP
  • Oura Health
  • Garmin
  • Neuralink
  • Synthego
  • Thync Global
  • Biohacker Center Store
  • OSTEOSTRONG
  • InteraXon（Muse）
  • Onnit
  • Bulletproof
  • NutriSense
  • OpenBCI
  • Cyborg Nest
Product Code: SMRC31455

According to Stratistics MRC, the Global Biohacking Supplements & Devices Market is accounted for $29.4 billion in 2025 and is expected to reach $99.1 billion by 2032 growing at a CAGR of 18.9% during the forecast period. Biohacking supplements and devices are tools designed to optimize human performance, longevity, and well-being through science-backed interventions. These include nootropics, adaptogens, wearables, neurostimulation gadgets, and metabolic trackers. Users aim to enhance cognitive function, sleep, energy, and cellular health. Popular among wellness enthusiasts and tech-savvy consumers, biohacking blends biology, nutrition, and technology to push the boundaries of personal health, often with a DIY ethos and a focus on measurable, data-driven outcomes.

According to the American Nutrition Association (ANA), biohacking technologies and supplements are advancing self-optimization through precision nutrition, nootropic formulations, and wearable biosensors for enhanced cognitive and metabolic performance.

Market Dynamics:

Driver:

Growing adoption of wearable health trackers

The market is propelled by the rising use of wearable devices that monitor vital signs, sleep patterns, and physical activity, enabling individuals to track their biohacking progress in real time. Spurred by advancements in sensor technology, these tools integrate seamlessly into daily routines. Consumers are increasingly leveraging wearables to support personalized wellness, preventive healthcare, and longevity practices. The popularity of smartwatches, fitness bands, and implantable trackers strengthens adoption. This growing reliance on digital monitoring enhances the accessibility and scalability of biohacking solutions.

Restraint:

High cost of advanced biohacking devices

The market faces challenges due to the significant cost burden associated with advanced biohacking technologies. Devices such as implantable chips, continuous glucose monitors, and neurostimulation tools remain expensive, restricting accessibility for mass consumers. High R&D investments and manufacturing complexities further elevate pricing structures. Additionally, many insurers exclude coverage for enhancement-based devices, labeling them elective rather than essential. These cost barriers confine adoption primarily to affluent consumers and early adopters. Consequently, affordability remains a critical restraint, slowing wider-scale market penetration.

Opportunity:

Integration with AI-driven personalized wellness

A major opportunity lies in the integration of artificial intelligence with biohacking solutions to provide individualized wellness pathways. AI-driven analytics can interpret large datasets from wearables, diagnostics, and supplements, offering actionable insights for users. Spurred by digital health advancements, this enables predictive monitoring of metabolic, cognitive, and hormonal markers. Personalized recommendations optimize supplementation, diet, and exercise regimens. Moreover, AI platforms enhance engagement through adaptive feedback loops. This convergence of biohacking with AI innovation is expected to reshape the market with scalable, data-driven solutions.

Threat:

Ethical concerns around human enhancement

The biohacking market encounters significant threats from growing ethical debates around human augmentation and enhancement practices. Public skepticism often centers on safety, privacy, and fairness in access to advanced biohacking tools. Critics argue that neuro-enhancement and genetic modification raise moral concerns about altering natural human performance. Regulatory bodies increasingly scrutinize these technologies for long-term impacts and misuse. Such ethical challenges can lead to stricter policies and hinder consumer confidence. Consequently, addressing societal concerns remains vital for sustainable market growth.

Covid-19 Impact:

The pandemic reshaped consumer perspectives on biohacking and preventive wellness. Heightened awareness of immunity, stress management, and overall resilience accelerated interest in supplements and digital monitoring devices. At the same time, global supply chain disruptions and high device costs temporarily slowed product availability. Telehealth adoption and increased online sales of nootropics, wearables, and wellness tools compensated for offline declines. Post-pandemic, consumers maintain stronger health-conscious habits, sustaining momentum for biohacking innovations. Overall, Covid-19 acted as a catalyst, deepening engagement with holistic self-optimization practices worldwide.

The nootropics segment is expected to be the largest during the forecast period

The nootropics segment is expected to account for the largest market share during the forecast period, owing to growing consumer interest in cognitive enhancement and mental performance. Supplements targeting focus, memory, and stress reduction are increasingly embraced by students, professionals, and aging populations. Spurred by rising work-life stress, demand for natural and synthetic nootropic formulations is surging. Online availability and subscription models enhance accessibility. Moreover, strong marketing around brain health strengthens uptake. This segment remains dominant as a cornerstone of biohacking adoption.

The AI-based monitoring segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the AI-based monitoring segment is predicted to witness the highest growth rate impelled by advancements in real-time data analytics and wearable integration. These platforms provide predictive insights into metabolism, sleep, and stress management, optimizing individual wellness strategies. Spurred by rapid adoption of smart devices, consumers increasingly seek AI-enabled personalization. Cloud-based platforms further enhance scalability and accessibility. Healthcare providers and biohackers alike are integrating AI to refine recommendations. This convergence of AI and biohacking positions monitoring technologies as a high-growth frontier.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by expanding health-conscious populations, increasing disposable incomes, and rapid adoption of smart wellness devices. Countries like China, Japan, South Korea, and India are fueling growth with strong demand for nootropics and wearable technologies. Traditional health practices combined with modern biohacking supplements further strengthen regional uptake. Rising investment in digital health infrastructure amplifies accessibility. Collectively, these factors cement Asia Pacific as the dominant contributor to global biohacking revenues.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR attributed to strong technological innovation and early adoption of biohacking solutions. Consumers in the U.S. and Canada are highly receptive to nootropics, genetic testing kits, and wearable health trackers. The presence of leading biotech companies and wellness startups accelerates product development. Additionally, the region's robust digital ecosystem supports AI-driven monitoring adoption. Growing interest in personalized wellness and preventive care further fuels momentum. These dynamics establish North America as the fastest-growing market region.

Key players in the market

Some of the key players in Biohacking Supplements & Devices Market include Apple, Fitbit, Health Via Modern Nutrition (HVMN), WHOOP, Oura Health, Garmin, Neuralink, Synthego, Thync Global, Biohacker Center Store, OSTEOSTRONG, InteraXon (Muse), Onnit, Bulletproof, NutriSense, OpenBCI and Cyborg Nest.

Key Developments:

In October 2025, Oura Health released its Ceramic Collection of smart rings, offering premium zirconia ceramic finishes in four new color options and a USB-C charging case priced at US$99. The update also includes a new "Health Panels" feature: Oura users can now access over 50 blood biomarkers via a partnership with Quest Diagnostics

In September 2025, Oura Health also forged a partnership with Progyny, a women's health and family building solutions platform, to integrate Oura's biometric data into Progyny's care offerings.

In May 2025, WHOOP introduced two new wearables, the WHOOP 5.0 and WHOOP MG (Medical Grade), which are ~7% smaller than the previous WHOOP 4.0 model and boast ≈14-day battery life.

Product Types Covered:

  • Nootropics
  • Adaptogens
  • Metabolic Boosters
  • Sleep Aids
  • Implants

Technologies Covered:

  • AI-Based Monitoring
  • IoT Devices
  • Data Analytics

Applications Covered:

  • Cognitive Enhancement
  • Physical Performance
  • Longevity
  • Stress Reduction
  • Sleep Optimization

End Users Covered:

  • Athletes
  • Working Professionals
  • Biohackers
  • Health Enthusiasts
  • Aging Population

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biohacking Supplements & Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 Nootropics
  • 5.3 Adaptogens
  • 5.4 Metabolic Boosters
  • 5.5 Sleep Aids
  • 5.6 Implants

6 Global Biohacking Supplements & Devices Market, By Technology

  • 6.1 Introduction
  • 6.2 AI-Based Monitoring
  • 6.3 IoT Devices
  • 6.4 Data Analytics

7 Global Biohacking Supplements & Devices Market, By Application

  • 7.1 Introduction
  • 7.2 Cognitive Enhancement
  • 7.3 Physical Performance
  • 7.4 Longevity
  • 7.5 Stress Reduction
  • 7.6 Sleep Optimization

8 Global Biohacking Supplements & Devices Market, By End User

  • 8.1 Introduction
  • 8.2 Athletes
  • 8.3 Working Professionals
  • 8.4 Biohackers
  • 8.5 Health Enthusiasts
  • 8.6 Aging Population

9 Global Biohacking Supplements & Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Apple
  • 11.2 Fitbit
  • 11.3 Health Via Modern Nutrition (HVMN)
  • 11.4 WHOOP
  • 11.5 Oura Health
  • 11.6 Garmin
  • 11.7 Neuralink
  • 11.8 Synthego
  • 11.9 Thync Global
  • 11.10 Biohacker Center Store
  • 11.11 OSTEOSTRONG
  • 11.12 InteraXon (Muse)
  • 11.13 Onnit
  • 11.14 Bulletproof
  • 11.15 NutriSense
  • 11.16 OpenBCI
  • 11.17 Cyborg Nest

List of Tables

  • Table 1 Global Biohacking Supplements & Devices Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Biohacking Supplements & Devices Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Biohacking Supplements & Devices Market Outlook, By Nootropics (2024-2032) ($MN)
  • Table 4 Global Biohacking Supplements & Devices Market Outlook, By Adaptogens (2024-2032) ($MN)
  • Table 5 Global Biohacking Supplements & Devices Market Outlook, By Metabolic Boosters (2024-2032) ($MN)
  • Table 6 Global Biohacking Supplements & Devices Market Outlook, By Sleep Aids (2024-2032) ($MN)
  • Table 7 Global Biohacking Supplements & Devices Market Outlook, By Implants (2024-2032) ($MN)
  • Table 8 Global Biohacking Supplements & Devices Market Outlook, By Technology (2024-2032) ($MN)
  • Table 9 Global Biohacking Supplements & Devices Market Outlook, By AI-Based Monitoring (2024-2032) ($MN)
  • Table 10 Global Biohacking Supplements & Devices Market Outlook, By IoT Devices (2024-2032) ($MN)
  • Table 11 Global Biohacking Supplements & Devices Market Outlook, By Data Analytics (2024-2032) ($MN)
  • Table 12 Global Biohacking Supplements & Devices Market Outlook, By Application (2024-2032) ($MN)
  • Table 13 Global Biohacking Supplements & Devices Market Outlook, By Cognitive Enhancement (2024-2032) ($MN)
  • Table 14 Global Biohacking Supplements & Devices Market Outlook, By Physical Performance (2024-2032) ($MN)
  • Table 15 Global Biohacking Supplements & Devices Market Outlook, By Longevity (2024-2032) ($MN)
  • Table 16 Global Biohacking Supplements & Devices Market Outlook, By Stress Reduction (2024-2032) ($MN)
  • Table 17 Global Biohacking Supplements & Devices Market Outlook, By Sleep Optimization (2024-2032) ($MN)
  • Table 18 Global Biohacking Supplements & Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 19 Global Biohacking Supplements & Devices Market Outlook, By Athletes (2024-2032) ($MN)
  • Table 20 Global Biohacking Supplements & Devices Market Outlook, By Working Professionals (2024-2032) ($MN)
  • Table 21 Global Biohacking Supplements & Devices Market Outlook, By Biohackers (2024-2032) ($MN)
  • Table 22 Global Biohacking Supplements & Devices Market Outlook, By Health Enthusiasts (2024-2032) ($MN)
  • Table 23 Global Biohacking Supplements & Devices Market Outlook, By Aging Population (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.